Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Efficacy of Pulsed Dye Laser in Dermatophytosis

This study has been completed.
Sponsor:
Information provided by:
Shahid Beheshti Medical University
ClinicalTrials.gov Identifier:
NCT00351897
First received: July 12, 2006
Last updated: February 19, 2008
Last verified: July 2007
  Purpose

The purpose of this study is to determine whether Pulsed Dye Laser therapy are effective in the treatment of Cutaneous Dermatophytosis.


Condition Intervention Phase
Cutaneous Dermatophytosis
Pulsed Dye Laser
Device: pulsed dye (585nm) laser therapy
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Efficacy of Pulsed Dye Laser in Dermatophytosis

Resource links provided by NLM:


Further study details as provided by Shahid Beheshti Medical University:

Primary Outcome Measures:
  • smear & culture of skin scrap

Enrollment: 10
Study Start Date: April 2006
Study Completion Date: September 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Detailed Description:

This study was conducted to determine the efficacy of Pulse Dye Laser in skin fungal infection, if this study showed that Laser could be effective, this would be introduced as a new treatment modality.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with Positive KOH Smear skin plaques

Exclusion Criteria:

  • Tinea Capitis,Onychomycosis
  • Pregnancy and feeding
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00351897

Locations
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University
Tehran, Iran, Islamic Republic of, 19899
Sponsors and Collaborators
Shahid Beheshti Medical University
Investigators
Study Director: Nima Ostovari, M.D. Shahid Beheshti Medical University
Study Chair: Parviz Toossi, MD Shahid Beheshti Medical University
  More Information

No publications provided

Responsible Party: Dr.Nima Ostovari
ClinicalTrials.gov Identifier: NCT00351897     History of Changes
Other Study ID Numbers: src-ost-1358
Study First Received: July 12, 2006
Last Updated: February 19, 2008
Health Authority: Iran: Ethics Committee

Additional relevant MeSH terms:
Dermatomycoses
Tinea
Infection
Mycoses
Skin Diseases
Skin Diseases, Infectious

ClinicalTrials.gov processed this record on November 20, 2014